Your browser doesn't support javascript.
loading
Clinical benefit of early treatment with bone-modifying agents for preventing skeletal-related events in patients with genitourinary cancer with bone metastasis: A multi-institutional retrospective study.
Owari, Takuya; Miyake, Makito; Nakai, Yasushi; Hori, Shunta; Tomizawa, Mitsuru; Ichikawa, Kazuki; Shimizu, Takuto; Iida, Kota; Samma, Shoji; Iemura, Yusuke; Momose, Hitoshi; Omori, Chihiro; Otani, Takeshi; Kuwada, Masaomi; Hirao, Shuya; Oyama, Nobuo; Nakagawa, Yoshinori; Hayashi, Yoshiki; Tanaka, Nobumichi; Fujimoto, Kiyohide.
Affiliation
  • Owari T; Department of Urology, Nara Medical University, Kashihara, Nara, Japan.
  • Miyake M; Department of Urology, Nara Medical University, Kashihara, Nara, Japan.
  • Nakai Y; Department of Urology, Nara Medical University, Kashihara, Nara, Japan.
  • Hori S; Department of Urology, Nara Medical University, Kashihara, Nara, Japan.
  • Tomizawa M; Department of Urology, Nara Medical University, Kashihara, Nara, Japan.
  • Ichikawa K; Department of Urology, Nara Medical University, Kashihara, Nara, Japan.
  • Shimizu T; Department of Urology, Nara Medical University, Kashihara, Nara, Japan.
  • Iida K; Nara Urological Research and Treatment Group, Nara, Nara, Japan.
  • Samma S; Department of Urology, Yamatotakada Municipal Hospital, Yamatotakada, Nara, Japan.
  • Iemura Y; Nara Urological Research and Treatment Group, Nara, Nara, Japan.
  • Momose H; Department of Urology, Nara Prefecture General Medical Center, Nara, Nara, Japan.
  • Omori C; Nara Urological Research and Treatment Group, Nara, Nara, Japan.
  • Otani T; Department of Urology, Nara Prefecture General Medical Center, Nara, Nara, Japan.
  • Kuwada M; Nara Urological Research and Treatment Group, Nara, Nara, Japan.
  • Hirao S; Department of Urology, Hoshigaoka Medical Center, Hirakata, Osaka, Japan.
  • Oyama N; Nara Urological Research and Treatment Group, Nara, Nara, Japan.
  • Nakagawa Y; Department of Urology, Hoshigaoka Medical Center, Hirakata, Osaka, Japan.
  • Hayashi Y; Nara Urological Research and Treatment Group, Nara, Nara, Japan.
  • Tanaka N; Department of Urology, Matsuzaka General Hospital, Matsuzaka, Mie, Japan.
  • Fujimoto K; Nara Urological Research and Treatment Group, Nara, Nara, Japan.
Int J Urol ; 26(6): 630-637, 2019 06.
Article in En | MEDLINE | ID: mdl-30883931
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms / Urogenital Neoplasms / Bone Density Conservation Agents Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Int J Urol Journal subject: UROLOGIA Year: 2019 Document type: Article Affiliation country: Japón Country of publication: Australia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms / Urogenital Neoplasms / Bone Density Conservation Agents Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Int J Urol Journal subject: UROLOGIA Year: 2019 Document type: Article Affiliation country: Japón Country of publication: Australia